FARMINGDALE, N.Y.--(BUSINESS WIRE)--Jan. 19, 2006--Enzo Biochem, Inc. (NYSE:ENZ) announced the election of three directors at the Company’s annual meeting today, as well as approval of the Company’s 2005 Equity Compensation Incentive Plan. The three Class III directors, each elected to three year terms, include Elazar Rabbani, Ph.D., Chairman, Chief Executive Officer and founder of Enzo; John B. Sias, former President and Chief Executive Officer of Chronicle Publishing Company; and Marcus A. Conant, MD, Clinical Professor at the University of California San Francisco. Mr. Sias and Dr. Conant have served on the Enzo Board since 1982 and 2004, respectively.
